pharma giles wonderful post fake antipsychotic dubious marketing similar real ad campaign geodon post pharma giles hilarious fda letter slaps pfizer false marketing geodon worth read well geodon featured medical journal ad offended sensibilities fda highlights specifically journal ad fails include warnings neuroleptic malignant syndrome tardive dyskinesia hyperglycemia diabetes mellitus journal ad mention movement disorders low eps object claims presentations insufficient communicate risk concepts associated seriousness tardive dyskinesia additionally professional journal ad fails include important precautions specifically rash orthostatic hypotension seizures omitting risks journal ad misleadingly suggests geodon injection safer demonstrated ad made claim proven advantages haloperidol im twice improvement measured bprs fda letter said presentation misleading implies geodon injection effective haloperidol im demonstrated substantial evidence substantial clinical experience single study cited claim open label study appropriate study design evaluate subjective endpoints measured brief psychiatric rating scale anchored version bprs potential evaluator bias fact fda aware substantial evidence support claim nice going pfizer keep advertising shoddy science